Targeting Myeloid-Derived Suppressor Cells Using a Novel Adenosine Monophosphate-Activated Protein Kinase (AMPK) Activator
OncoImmunology - United States
doi 10.1080/2162402x.2016.1214787
Full Text
Open PDFAbstract
Available in full text
Date
July 25, 2016
Authors
Publisher
Informa UK Limited